Can higher triglycerides, lower HDL cholesterol, and lower SHBG signal insulin resistance even with normal fasting insulin and HbA1c?

Higher triglycerides, lower HDL cholesterol, and lower SHBG can be a meaningful metabolic pattern in a 53-year-old woman, particularly around or after menopause, but it should be interpreted as a risk signal rather than a diagnosis of insulin resistance.

Clinical and cardiometabolic significance

• Higher triglycerides and lower HDL-C are established features of an adverse cardiometabolic-risk profile and are associated with insulin resistance.
• Lower SHBG provides additional biologic and observational support. In postmenopausal women, lower SHBG has been inversely associated with HOMA-IR, including longitudinal observations. SHBG also correlates with triglyceride and HDL measures in this population.
• The combined pattern therefore supports increased suspicion for insulin resistance and, more directly, elevated cardiometabolic risk. SHBG itself is not part of routine recommended adult metabolic-risk assessment.

Interpreting normal fasting insulin and HbA1c

• A normal HbA1c does not exclude insulin resistance: HbA1c measures average glycemia, whereas insulin resistance can precede detectable dysglycemia.
• Normal fasting insulin is also not reliably exclusionary because there are no universally validated fasting-insulin cutoffs for diagnosing or ruling out insulin resistance.
• However, normal fasting insulin and HbA1c do not confirm that insulin resistance is present; the specific triglyceride–HDL–SHBG combination has not been validated as a diagnostic panel in people with both values normal.

Mechanistic and methodological context

• Insulin-resistant metabolic states commonly promote triglyceride-rich lipoproteins and lower HDL-C. Lower SHBG is biologically linked to this broader metabolic phenotype, but available evidence is largely observational and often uses HOMA-IR rather than direct insulin-sensitivity measures such as clamp testing.
• No supplied evidence provides diagnostic sensitivity, specificity, or universal thresholds for the three-marker pattern.

Bottom line

• This pattern is plausibly consistent with insulin resistance despite normal HbA1c and fasting insulin, but it is best regarded as an indicator of cardiometabolic risk—not a validated diagnostic test for insulin resistance.